Published in Obesity and Diabetes Week, May 16th, 2005
Phentermine hydrochloride is indicated for the short-term management of obesity and is the generic equivalent of Adipex-P, marketed by Gate Pharmaceuticals, a division of Teva Pharmaceutical Industries.
According to NDC Health (originally National Data Corporation), the total U.S. market for Phentermine Hydrochloride 37.5 mg tablets is approximately $84 million. Currently, there...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.